147 related articles for article (PubMed ID: 6809312)
1. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.
Berrigan MJ; Marinello AJ; Pavelic Z; Williams CJ; Struck RF; Gurtoo HL
Cancer Res; 1982 Sep; 42(9):3688-95. PubMed ID: 6809312
[TBL] [Abstract][Full Text] [Related]
2. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
Goel A; Dani V; Dhawan DK
Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
[TBL] [Abstract][Full Text] [Related]
3. Interaction of endosulfan and dietary vitamin A on rat hepatic drug metabolising enzymes.
Sriram K; Misra UK
Acta Vitaminol Enzymol; 1983; 5(4):213-8. PubMed ID: 6424426
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
Ormstad K; Ohno Y
Cancer Res; 1984 Sep; 44(9):3797-800. PubMed ID: 6430554
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo.
Murray M; Wilkinson CF; Marcus C; Dubé CE
Mol Pharmacol; 1983 Jul; 24(1):129-36. PubMed ID: 6865922
[TBL] [Abstract][Full Text] [Related]
7. Protection by N-acetylcysteine of cyclophosphamide metabolism - related in vivo depression of mixed function oxygenase activity and in vitro denaturation of cytochrome P-450.
Berrigan MJ; Gurtoo HL; Sharma SD; Struck RF; Marinello AJ
Biochem Biophys Res Commun; 1980 Apr; 93(3):797-803. PubMed ID: 7387676
[No Abstract] [Full Text] [Related]
8. Influence of (+)-propoxyphene on the hexachlorobenzene-induced porphyria of rats.
Merk H; von Zittwitz A; Bolsen K; Goerz G
Arzneimittelforschung; 1985; 35(11):1685-7. PubMed ID: 3879174
[TBL] [Abstract][Full Text] [Related]
9. Chemoprotection against cyclophosphamide-induced urotoxicity: comparison of nine thiol protective agents.
Roberts JC; Francetic DJ; Zera RT
Anticancer Res; 1994; 14(2A):389-95. PubMed ID: 8017838
[TBL] [Abstract][Full Text] [Related]
10. Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.
Cavalletti E; Tofanetti O; Zunino F
Cancer Lett; 1986 Jul; 32(1):1-6. PubMed ID: 3091245
[TBL] [Abstract][Full Text] [Related]
11. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
Hietanen E; Ahotupa M; Heikelä A; Laitinen M
Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
[TBL] [Abstract][Full Text] [Related]
12. [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)].
Kunze E; Köhnecke B; Engelhardt W; Brock N; Pohl J
Arzneimittelforschung; 1983; 33(6):853-4. PubMed ID: 6412725
[TBL] [Abstract][Full Text] [Related]
13. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
Kedar A; Simpson CL; Williams P; Moore R; Tritsch G; Murphy GP
Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):339-48. PubMed ID: 6774389
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats.
McClure MT; Stupans I
Biochem Pharmacol; 1992 Jun; 43(12):2655-8. PubMed ID: 1632821
[TBL] [Abstract][Full Text] [Related]
15. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
Brock N; Stekar J; Pohl J; Niemeyer U; Scheffler G
Arzneimittelforschung; 1979; 29(4):659-61. PubMed ID: 114192
[TBL] [Abstract][Full Text] [Related]
16. Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide.
Gurtoo HL; Marinello AJ; Berrigan MJ; Bansal SK; Paul B; Pavelic ZP; Struck RF
Semin Oncol; 1983 Mar; 10(1 Suppl 1):35-45. PubMed ID: 6836326
[No Abstract] [Full Text] [Related]
17. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
Kunze E; Köhnecke B; Engelhardt W; Steinröder H; Brock N; Pohl J
Urol Int; 1984; 39(2):61-7. PubMed ID: 6426112
[TBL] [Abstract][Full Text] [Related]
18. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
Freedman A; Ehrlich RM; Ljung BM
J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
[TBL] [Abstract][Full Text] [Related]
19. [Hepatic microsomal monoxygenase inhibition by nabam in the rat (author's transl)].
Périquet A; Derache R
Toxicol Eur Res; 1981 Nov; 3(6):285-91. PubMed ID: 7330871
[TBL] [Abstract][Full Text] [Related]
20. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
Ozcan A; Korkmaz A; Oter S; Coskun O
Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
